To compare the safety and efficacy of Baerveldt implantation (Abbott Medical Optics, Santa Ana, CA) and trabeculectomy with mitomycin C (MMC) in patients who have not undergone prior incisional ocular surgery.

Although intravitreal injections are considered a great advancement in the management of retinal diseases because they have potential to improve vision, endophthalmitis is a concern to a treating ophthalmologist.1,2 Previous studies have found a prevalence of postinjection endophthalmitis of 0% to 0.87%. The purpose of this study is to report the incidence, microbiological profile, antimicrobial susceptibility, clinical findings, management, and visual outcomes in patients with acute postinjection endophthalmitis (within 6 weeks) after anti-vascular endothelial growth factor and intravitreal injection of triamcinolone acetonide (IVTA).

To characterize the rate and pattern of age-related and glaucomatous neuroretinal rim area changes in subjects of African and European descent.

To determine whether vitrectomy surgery rates have changed over the past decade and factors affecting the odds of undergoing this procedure.

Subthreshold depression is highly prevalent in visually impaired older adults and an important risk factor for major depressive disorder.1 For early diagnosis and treatment, it is important to identify patients who are at high risk of having subthreshold depression. Former research found inconsistent results and prediction models were never validated externally.2 Therefore, the aim of this study was to assess comprehensively potential predictor variables by internally validating a prediction model for subthreshold depression in a European sample and validating this model externally in a comparable Australian sample.

To describe morphologic and visual outcomes in eyes with angiographic cystoid macular edema (CME) treated with ranibizumab or bevacizumab for neovascular age-related macular degeneration (nAMD).